MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on May 18, 2005; DOI: 10.1124/mol.105.013391


0026-895X/05/6802-467-476$20.00
Mol Pharmacol 68:467-476, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.013391v1
68/2/467    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moulédous, L.
Right arrow Articles by Meunier, J.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moulédous, L.
Right arrow Articles by Meunier, J.-C.

Long-Term Morphine Treatment Enhances Proteasome-Dependent Degradation of G{beta} in Human Neuroblastoma SH-SY5Y Cells: Correlation with Onset of Adenylate Cyclase Sensitization

Lionel Moulédous, Jérémie Neasta, Sandrine Uttenweiler-Joseph, Alexandre Stella, Mariette Matondo, Maïthé Corbani, Bernard Monsarrat, and Jean-Claude Meunier

Institut de Pharmacologie et de Biologie Structurale, Centre National de la Recherche Scientifique, Toulouse, France

The initial aim of this study was to identify protein changes associated with long-term morphine treatment in a recombinant human neuroblastoma SH-SY5Y clone (sc2) stably overexpressing the human µ-opioid (MOP) receptor. In MOP receptor-overexpressing sc2 cells, short-term morphine exposure was found to be much more potent and efficacious in inhibiting forskolin-elicited production of cAMP, and long-term morphine exposure was shown to induce a substantially higher degree of opiate dependence, as reflected by adenylate cyclase sensitization, than it did in wild-type neuroblastoma cells. Differential proteomic analysis of detergent-resistant membrane rafts isolated from untreated and chronically morphine-treated sc2 cells revealed long-term morphine exposure to have reliably induced a 30 to 40% decrease in the abundance of five proteins, subsequently identified by mass spectrometry as G protein subunits {alpha}i2, {alpha}i3, {beta}1, and {beta}2, and prohibitin. Quantitative Western blot analyses of whole-cell extracts showed that long-term morphine treatment-induced down-regulation of G{beta} but not of the other proteins is highly correlated (r2 = 0.96) with sensitization of adenylate cyclase. Down-regulation of G{beta} and adenylate cyclase sensitization elicited by long-term morphine treatment were suppressed in the presence of carbobenzoxy-L-leucyl-L-leucyl-L-norvalinal (MG-115) or lactacystin. Thus, sustained activation of the MOP receptor by morphine in sc2 cells seems to promote proteasomal degradation of G{beta} to sensitize adenylate cyclase. Together, our data suggest that the long-term administration of opiates may elicit dependence by altering the neuronal balance of heterotrimeric G proteins and adenylate cyclases, with the ubiquitin-proteasome pathway playing a pivotal role.


Received April 1, 2005; accepted May 18, 2005

Address correspondence to: Dr. Jean-Claude Meunier, IPBS-CNRS UMR5089, 205 route de Narbonne, 31077 Toulouse cédex 04, France. E-mail: jean-claude.meunier{at}ipbs.fr




This article has been cited by other articles:


Home page
Circ. Res.Home page
S. K. Shenoy
Seven-Transmembrane Receptors and Ubiquitination
Circ. Res., April 27, 2007; 100(8): 1142 - 1154.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Roumy, C. Lorenzo, S. Mazeres, S. Bouchet, J.-M. Zajac, and C. Mollereau
Physical Association between Neuropeptide FF and {micro}-Opioid Receptors as a Possible Molecular Basis for Anti-opioid Activity
J. Biol. Chem., March 16, 2007; 282(11): 8332 - 8342.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. N. Yadav, K. Chaturvedi, and R. D. Howells
Inhibition of Agonist-Induced Down-Regulation of the {delta}-Opioid Receptor with a Proteasome Inhibitor Attenuates Opioid Tolerance in Human Embryonic Kidney 293 Cells
J. Pharmacol. Exp. Ther., March 1, 2007; 320(3): 1186 - 1194.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics